<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-11-11T22:07:33+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://acuity.news/technology/camber-ceo-christophe-rimann-ai-roi-healthcare-billing-revenue-cycle-2026/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T06:00:49-07:00</news:publication_date><news:title>AI ROI in Healthcare Billing Comes From Rebuilding the Process, Camber CEO Christophe Rimann Says. Apollo Sees No AI Payoff Outside Tech, and He Agrees.</news:title></news:news></url>
<url><loc>https://acuity.news/regulation/va-community-care-residential-substance-use-spending-gao-report-2026/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-10T11:55:00-07:00</news:publication_date><news:title>VA Community Care Spent $1.9 Billion on Residential Substance Use Treatment in Four Years, 43 Percent of Behavioral Health Referral Dollars</news:title></news:news></url>
<url><loc>https://acuity.news/technology/neurora-fda-clearance-ai-biometrics-autism-diagnosis-frazier-2026/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-10T05:53:18-07:00</news:publication_date><news:title>Neurora FDA Clearance Brings AI Biometrics to Autism Diagnosis. CentralReach’s Dr. Thomas Frazier Says Clinician Confidence Could Shorten Wait Lists.</news:title></news:news></url>
</urlset>
